Clinical Trial: Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763821) titled 'Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.' on Aug. 09.

Brief Summary: This study will identify the level of serum Riboneuclease 1 in systemic lupus patients and compare between its level in lupus nephritis and non nephritis.

Study Start Date: Sept. 30

Study Type: OBSERVATIONAL

Condition: System Lupus Erythematosus(SLE)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Amira Mohammad Abdalmageed Mansour, Assiut University

Published by HT Digital Content Services with permission from Health Daily Digest....